Pacofarst (Codeine Phosphate Sesquihydrate, Paracetamol)

Codeine phosphate sesquihydrate, the active ingredient in Pacofarst, is a combination analgesic presented as a tablet for oral use. It treats mild to moderate pain and reduces fever in adult patients. GNH USA supplies Pacofarst as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pacofarst as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pacofarst is a combination analgesic that acts on pain‑related pathways and fever mechanisms.

- Mild to moderate acute pain: provides relief when non‑opioid analgesics are insufficient. - Post‑operative pain: helps control discomfort after surgical procedures. - Fever associated with viral or bacterial infections: reduces elevated body temperature. - Dental pain: alleviates pain following dental extractions or procedures. - Musculoskeletal pain: eases discomfort from strains, sprains or low‑back pain.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel movements. - Drowsiness: feeling of sleepiness or reduced alertness. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation. - Sweating: increased perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, especially at higher doses. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatotoxicity: liver injury from excessive paracetamol exposure. - Dependence or misuse potential: risk of opioid‑related dependence. - Severe hypotension: marked drop in blood pressure. - Seizures: rare convulsive episodes.

When using Pacofarst, consider several 

-      "); -   ... ... ... ... ... ... ... ... ...   """""  ...  """  ""  "" """ ....  """""  "…  "  """""" " "" "… … "" "" "" " … … "" "  "" " " "" "  " "" "" ");"  \